Introduction
kinson's disease and related alpha-synucleinopathies. Despite predominant localization in the 54 cytosol, αsyn is found localized to mitochondria in post-mortem Parkinson's disease brain 55 (Devi et al., 2008) . Mitochondrial accumulation of αsyn has been associated with impairment 56 of complex-I dependent respiration, decreased mitochondria membrane potential, and in-57 creased levels of mitochondrial reactive oxygen species (mtROS) in multiple cellular models 58 (Hsu et al., 2000; Devi et al., 2008; Reeve et al., 2015; Ludtmann et al., 2018) . The evidence 59 supporting a contribution of abnormal accumulation of αsyn to disruption of mitochondrial 60 processes is compelling and indicates a crucial role for αsyn-induced mitochondrial dysfunc-61 tion in Parkinson's disease pathogenesis and alpha-synucleopathies. coelenterazine (20mM, NanoLight).
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Western blotting analysis
151
To prepare whole cell lysates, cells were washed twice with ice-cold PBS and total proteins 152 were isolated by incubating the cells on ice in radio-immunoprecipitation assay (RIPA) lysis 153 buffer (50mM Tris-HCl, pH 7.4, 150mM NaCl, 1mM EDTA, 1mM EGTA, 1.2% Triton X-154 100, 0.5% sodium deoxycholate, and 0.1% SDS) containing 1mM phenylmethylsulfonyl flu-155 oride (PMSF), protease inhibitor cocktail, and halt phosphatase inhibitor cocktail. Collected 156 cells were sonicated on ice and centrifuged at 10,000 × g for 10min at 4°C. The protein con-medium and incubated with 2.5μM MitoSOX Red reagent in the dark at 37°C. Cells were 213 washed gently three times with warm PBS buffer and imaged immediately after, under fluo-214 rescence microscopy.
215
Statistical analysis
216
All data were analyzed by the Graph Pad Prism 7 software (San Diego, CA) and statistical 
222
Data Availability
223
Data sharing is not applicable to this article as no new data were created or analyzed in this 224 study.
226
Results
227
Increased αsyn oligomers in mitochondria correlate with decreased SIRT3 protein levels 228 Although it has been described previously that αsyn localizes to mitochondria and αsyn over-229 expressing cells exhibit mitochondrial dysfunction (Devi et al., 2008; Marongiu et al., 2009; 230 Nakamura et al., 2011) the relationship between αsyn oligomers and mitochondria in patho-231 logic conditions and the mechanisms whereby αsyn induces mitochondrial dysfunction are 232 still poorly understood. Herein, we use a previously described inducible cell model of human 233 αsyn overexpression that results in formation of intracellular oligomeric species over time 234 (Moussaud et al., 2015) . This tetracycline-off (Tet-off) stable cell line facilitates monitoring 235 of αsyn oligomerization in situ via a split luciferase protein-fragment complementation assay.
236
To determine if αsyn oligomeric species are localized within mitochondria, cells were har-237 vested at various time points after tetracycline removal, mitochondrial-enriched fractions 238 were isolated, and luciferase activity was measured as a surrogate for αsyn oligomeric species.
239
Luciferase activity increased in a time-dependent manner in both the mitochondrial (Fig. 1A   240 and B) and cytosolic fractions (Suppl. Fig. 1A ) of the cells. Increased αsyn oligomers were 241 confirmed by the detection of increased high molecular weight species in both compartments 242 72h after removal of tetracycline (Suppl. Fig. 1B ). GAPDH and COXIV immunoblotting confirmed purity of mitochondrial fractionation (Figs. 1A and B) . Interestingly, the increase 244 in mitochondrial-localized αsyn oligomers was accompanied by a decrease in SIRT3 protein 245 levels beginning 12h after αsyn expression was turned on, and becoming significant by 24h 246 (Fig. 1A) . Immunocytochemistry confirmed decreased SIRT3 immunofluorescence in cells 247 accumulating αsyn oligomers (Suppl. Fig. 1C , Tet-72h) compared to control (Suppl. Fig. 1C, 
248
Tet+ 72h). In support of a αsyn-mediated effect on SIRT3 levels, knockdown of SIRT3 in-249 creased αsyn oligomers with a corresponding increase in αsyn protein levels (Figs. 1C and D) . (Fig. 1A) , we detected a significant decrease in p-
261
AMPKα (Thr172) and p-CREB (Ser133) ( Fig. 2A and B) . AMPKα-CREB signaling was also were treated with 2 mM AICAR for 2h in accordance with a previous study (Takeuchi et al., 268 2013), and harvested 72h after tetracycline removal. A significant increase in p-AMPKα and 269 p-CREB levels was observed ( Fig. 2A , #P<.0.05) and importantly, led to a partial restoration 270 of SIRT3 levels to control levels (Fig. 2B, #P<0 .05) and significantly decreased the level of 271 αsyn oligomers (Fig. 2C) . Because SIRT3 is a deacetylase known to modulate the acetylation activity. Of note, αsyn overexpression had no effect on total SOD2 levels which remained consistent in all conditions (Fig. 2D ). In the presence of αsyn oligomers, DRP1 is recruited from the cytosol to the mitochondria 299 (Fig. 4A) . Consistent with the fact that phosphorylation of DRP1 at serine 616 activates mito-300 chondrial fission, we detected increased levels of p-DRP1 in cells overexpressing αsyn 301 (Suppl. Fig. 3 ). By contrast, OPA1 protein levels decreased over time in the mitochondrial 302 fraction (Fig. 4A) , consistent with a decrease in mitochondrial fusion. Several lines of evi-303 dence suggest that a decrease in OPA1 and the translocation of DRP1 to the mitochondria are 304 crucial events that lead to mitochondrial fragmentation. When we evaluated the effect of 305 AICAR on mitochondria dynamics we found OPA1 level in mitochondria restored (Fig. 4B) 
306
and phosphorylation of DRP1 significantly decreased (Fig. 4C) . To determine if accumulation 307 of αsyn in the mitochondria affects cellular bioenergetics we measured the oxygen consump-308 tion rate (OCR) in cell lysates using the Seahorse XF96 analyzer. The OCR was measured with DRP1 significantly increased in the injected SN (Fig. 6B, *P<0 .05) and OPA1 signifi-cantly decreased (Fig. 6B, *P<0.05) . Lastly, AMPKα-CREB signaling was downregulated in the SN of these animals (Suppl. Fig. 4B ), mimicking once again our in vitro observation.
344
SIRT3 levels are decreased in human Lewy body disease brains.
345 Lastly, we assessed the level of SIRT3 in human post mortem brain with a confirmed neuro-346 pathological diagnosis of Lewy body disease (LBD) ( Table 1) . Frozen striatal tissue from 10 347 LBD and 10 healthy controls was homogenized, run on SDS-PAGE, and probed with anti-348 bodies to detect SIRT3, OPA1, and DRP1. Western blot analyses showed significantly re-349 duced expression of SIRT3 in LBD brains compared to controls (Fig. 7A and B) . We also 350 detected reduced expression of OPA1 protein but no significant difference in the level of 351 DRP1 compared to controls ( Fig. 7A and B) . Brains from both sexes were utilized but there 352 was no difference in the interpretation of the data when stratified by sex (data not shown).
353
Together, these results are consistent with our findings from cell and rodent models with de-354 creased SIRT3 protein levels when αsyn accumulates and aggregates in neurons. Figure Legends the mean ± S.E.M (n = 4-5 rats). *P < 0.05, **P < 0.01 compared to control conditions. n.s:
681 not significant. supported by data in this manuscript.
